{"id":"https://openalex.org/W2885723055","doi":"https://doi.org/10.1158/1538-7445.am2018-2728","title":"Abstract 2728: Circulating levels of Resokine, a soluble modulator of the immune system, are upregulated in both experimental cancer models and in patients across multiple tumor types","display_name":"Abstract 2728: Circulating levels of Resokine, a soluble modulator of the immune system, are upregulated in both experimental cancer models and in patients across multiple tumor types","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885723055","doi":"https://doi.org/10.1158/1538-7445.am2018-2728","mag":"2885723055"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-2728","doi":"https://doi.org/10.1158/1538-7445.am2018-2728","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2728","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111952025","display_name":"Ryan A. Adams","orcid":"https://orcid.org/0000-0001-5602-3971","observed_orcids":["https://orcid.org/0000-0001-5602-3971"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Adams","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034881245","display_name":"Elisabeth Mertsching","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth Mertsching","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056710753","display_name":"Leslie A. Nangle","orcid":"https://orcid.org/0009-0000-6953-7998","observed_orcids":["https://orcid.org/0009-0000-6953-7998"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Nangle","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085917187","display_name":"Kathy Ogilvie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathy Ogilvie","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113785989","display_name":"Steven Crampton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Crampton","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Bruner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Bruner","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068770209","display_name":"Samantha K. Tyler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Tyler","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029054532","display_name":"Sanna Rosengren","orcid":"https://orcid.org/0000-0002-2135-8285","observed_orcids":["https://orcid.org/0000-0002-2135-8285"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanna Rosengren","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048191125","display_name":"Andrea Cubitt","orcid":"https://orcid.org/0009-0002-7452-1135","observed_orcids":["https://orcid.org/0009-0002-7452-1135"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Cubitt","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101541338","display_name":"David J. King","orcid":"https://orcid.org/0000-0003-3482-6049","observed_orcids":["https://orcid.org/0000-0003-3482-6049"]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David King","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018122687","display_name":"John D. Mendlein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151019","display_name":"aTyr Pharma (United States)","ror":"https://ror.org/05edt5833","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151019"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Mendlein","raw_affiliation_strings":["aTyr Pharma, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aTyr Pharma, San Diego, CA","institution_ids":["https://openalex.org/I4210151019"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210151019"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"2728","last_page":"2728"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0794999971985817,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04600000008940697,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histidyl-trna-synthetase","display_name":"histidyl-tRNA synthetase","score":0.8830000162124634},{"id":"https://openalex.org/keywords/t-cell-activation-inhibition","display_name":"T cell activation inhibition","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.7789999842643738},{"id":"https://openalex.org/keywords/circulating-biomarkers","display_name":"circulating biomarkers","score":0.8050000071525574},{"id":"https://openalex.org/keywords/tumor-size","display_name":"tumor size","score":0.375},{"id":"https://openalex.org/keywords/b16f10-melanoma","display_name":"B16F10 melanoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/syngeneic-tumors","display_name":"syngeneic tumors","score":0.7260000109672546},{"id":"https://openalex.org/keywords/granzyme-b","display_name":"granzyme B","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cytokine-inhibition","display_name":"cytokine inhibition","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cancer-immunotherapy-monitoring","display_name":"cancer immunotherapy monitoring","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.67857825756073},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.5390398502349854},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5245264172554016},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5244213342666626},{"id":"https://openalex.org/C2780380082","wikidata":"https://www.wikidata.org/wiki/Q12646460","display_name":"Granzyme B","level":4,"score":0.500377893447876},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4863465428352356},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4671938419342041},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44619446992874146},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4271087348461151},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42635005712509155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34539997577667236},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3409033417701721},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32866138219833374},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23968756198883057},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08824124932289124}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-2728","doi":"https://doi.org/10.1158/1538-7445.am2018-2728","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2728","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2789251620","https://openalex.org/W2887929911","https://openalex.org/W2334151804","https://openalex.org/W2276707627","https://openalex.org/W2364808681","https://openalex.org/W2148225186","https://openalex.org/W7099143165","https://openalex.org/W2005936795","https://openalex.org/W4324309777","https://openalex.org/W14648577"],"abstract_inverted_index":{"Abstract":[0],"Resokine":[1,15,30,83,99,111,170,194,216,297,314],"is":[2,32,46,63,84,289],"a":[3,21,33,49,223,317,353],"newly":[4],"identified":[5],"regulator":[6],"of":[7,14,104,129,141,144,156,158,168,193,234,277,285,310,313,320,351,356,377],"immune":[8,105,304,321,358],"cell":[9,28,90,115,255],"activity,":[10,305],"and":[11,43,92,122,137,152,154,211,306,367],"circulating":[12,169,272],"levels":[13,128,167,192,205,217,237,273,280,315,350],"in":[16,65,93,126,171,200,218,257,323,362,368],"normal":[17,188,219],"individuals":[18,235,278],"may":[19],"represent":[20],"soluble":[22,354],"set-point":[23],"control":[24],"to":[25,120,229,252,302],"modulate":[26],"T":[27,114,254],"activity.":[29],"activity":[31,45,283,322],"non-canonical":[34],"function":[35],"arising":[36,55],"from":[37,56,86,196,227],"the":[38,44,57,66,102,142,159,243,249,282,292,311,357,378],"tRNA":[39,80],"synthetase":[40,61,81],"gene":[41,58],"family,":[42],"effected":[47],"by":[48,118],"60":[50],"amino":[51],"acid":[52],"N-terminal":[53],"domain":[54],"for":[59,109,381],"histidyl-tRNA":[60],"which":[62,239],"present":[64],"full-length":[67],"protein":[68],"as":[69,71,133,149,177,179,242,298,316],"well":[70,178],"multiple":[72,184,371],"splice":[73],"variants":[74],"that":[75,98,294],"have":[76,96,165],"lost":[77],"their":[78],"original":[79],"functionality.":[82],"secreted":[85],"cells,":[87],"including":[88],"tumor":[89,185,214,268,372],"lines,":[91],"vitro":[94],"studies":[95],"demonstrated":[97],"can":[100,124],"inhibit":[101,253],"activation":[103,116,146,256],"cells.":[106],"In":[107,187,259],"vitro,":[108],"example,":[110],"addition":[112],"during":[113],"induced":[117],"antibodies":[119],"CD3":[121],"CD28,":[123],"result":[125],"reduced":[127],"inflammatory":[130],"cytokines":[131],"such":[132,148],"IL-2,":[134],"interferon":[135],"gamma,":[136],"TNF":[138],"alpha;":[139],"inhibition":[140,155],"up-regulation":[143],"cell-surface":[145],"markers,":[147],"CD69,":[150],"CD40L":[151],"4-1BB;":[153],"release":[157],"cytotoxic":[160],"mediator":[161],"granzyme":[162],"B.":[163],"We":[164],"tested":[166],"both":[172,363],"mice":[173,190,201],"with":[174,213,232,266,274,291],"syngeneic":[175],"tumors":[176,295],">300":[180,263],"cancer":[181,264,365],"patients":[182,265,369],"across":[183,262,370],"types.":[186],"C57Bl6":[189],"serum":[191],"ranged":[195],"70-250pM":[197],"(n=10)":[198],"whereas":[199],"bearing":[202],"B16F10":[203],"tumors,":[204],"were":[206],"significantly":[207],"higher":[208,271],"(450-3000pM,":[209],"p<0.001)":[210],"correlated":[212],"size.":[215],"human":[220],"volunteers":[221],"exhibit":[222],"more":[224],"variable":[225],"range,":[226],"8pM":[228],">2333pM":[230],"(n=148),":[231],"18%":[233],"having":[236,279],"<30pM,":[238],"was":[240],"set":[241],"active":[244],"threshold":[245,284],"level":[246],"based":[247],"on":[248],"concentration":[250],"required":[251],"vitro.":[258],"contrast,":[260],"samples":[261],"different":[267],"types,":[269],"exhibited":[270],"only":[275],"4%":[276],"below":[281],"30pM.":[286],"This":[287],"data":[288],"consistent":[290],"hypothesis":[293],"secrete":[296],"an":[299],"additional":[300],"mechanism":[301],"down-regulate":[303],"suggests":[307],"further":[308],"investigation":[309],"utility":[312],"new":[318],"biomarker":[319],"patients.":[324],"Citation":[325],"Format:":[326],"Ryan":[327],"Adams,":[328],"Elisabeth":[329],"Mertsching,":[330],"Leslie":[331],"Nangle,":[332],"Kathy":[333],"Ogilvie,":[334],"Steven":[335],"Crampton,":[336],"John":[337,347],"Bruner,":[338],"Samantha":[339],"Tyler,":[340],"Sanna":[341],"Rosengren,":[342],"Andrea":[343],"Cubitt,":[344],"David":[345],"King,":[346],"Mendlein.":[348],"Circulating":[349],"Resokine,":[352],"modulator":[355],"system,":[359],"are":[360],"upregulated":[361],"experimental":[364],"models":[366],"types":[373],"[abstract].":[374],"In:":[375],"Proceedings":[376],"American":[379],"Association":[380],"Cancer":[382,395],"Research":[383],"Annual":[384],"Meeting":[385],"2018;":[386],"2018":[387],"Apr":[388],"14-18;":[389],"Chicago,":[390],"IL.":[391],"Philadelphia":[392],"(PA):":[393],"AACR;":[394],"Res":[396],"2018;78(13":[397],"Suppl):Abstract":[398],"nr":[399],"2728.":[400]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2018-08-22T00:00:00"}